» Articles » PMID: 29286071

Molecular Regulation of Epithelial-to-mesenchymal Transition in Tumorigenesis (Review)

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2017 Dec 30
PMID 29286071
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous studies over the past two decades have focused on the epithelial‑to‑mesenchymal transition (EMT) and its role in the development of metastasis. Certain studies highlighted the importance of EMT in the dissemination of tumor cells and metastasis of epithelium‑derived carcinomas. Tumor metastasis is a multistep process during which tumor cells change their morphology, and start to migrate and invade distant sites. The present review discusses the current understanding of the molecular mechanisms contributing to EMT in embryogenesis, fibrosis and tumorigenesis. Additionally, the signaling pathways that initiate EMT through transcriptional factors responsible for the activation and suppression of various genes associated with cancer cell migration were investigated. Furthermore, the important role of the epigenetic modifications that regulate EMT and the reverse process, mesenchymal‑to‑epithelial transition (MET) are discussed. MicroRNAs are key regulators of various intracellular processes and current knowledge of EMT has significantly improved due to microRNA characterization. Their effect on signaling pathways and the ensuing events that occur during EMT at the molecular level is becoming increasingly recognized. The current review also highlights the role of circulating tumor cells (CTCs) and CTC clusters, and their ability to form metastases. In addition, the biological properties of different types of circulating cells based on their tumor‑forming potential are compared.

Citing Articles

Single-Cell Analysis of Bone-Marrow-Disseminated Tumour Cells.

So K, Su Z, Cheung J, Choi S Diagnostics (Basel). 2024; 14(19).

PMID: 39410576 PMC: 11475990. DOI: 10.3390/diagnostics14192172.


SMARCD3 Overexpression Promotes Epithelial-Mesenchymal Transition in Gastric Cancer.

Park S, Park J, Yang J, Jung E, Ju Y, Jeong C Cancers (Basel). 2024; 16(12).

PMID: 38927986 PMC: 11201906. DOI: 10.3390/cancers16122282.


New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets.

Hussen B, Abdullah K, Abdullah S, Majeed N, Mohamadtahr S, Rasul M Noncoding RNA Res. 2023; 8(4):645-660.

PMID: 37818447 PMC: 10560790. DOI: 10.1016/j.ncrna.2023.09.003.


The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma.

Ghionescu A, Sorop A, Dima S Front Pharmacol. 2023; 14:1270425.

PMID: 37767397 PMC: 10520284. DOI: 10.3389/fphar.2023.1270425.


Molecular determinants of epithelial mesenchymal transition in mouse placenta and trophoblast stem cell.

Jena S, Das S, Chakraborty S, Ain R Sci Rep. 2023; 13(1):10978.

PMID: 37414855 PMC: 10325982. DOI: 10.1038/s41598-023-37977-2.


References
1.
Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S . Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci. 2013; 14(10):21087-113. PMC: 3821660. DOI: 10.3390/ijms141021087. View

2.
Caplakova V, Babusikova E, Blahovcova E, Balharek T, Zelieskova M, Hatok J . DNA Methylation Machinery in the Endometrium and Endometrial Cancer. Anticancer Res. 2016; 36(9):4407-20. DOI: 10.21873/anticanres.10984. View

3.
Yeung K, Yang J . Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017; 11(1):28-39. PMC: 5242415. DOI: 10.1002/1878-0261.12017. View

4.
Chang M, Chang Y, Chen J, Jeng Y, Yang C, Tien Y . Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma. Clin Chem. 2016; 62(3):505-13. DOI: 10.1373/clinchem.2015.248260. View

5.
Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View